Mode
Text Size
Log in / Sign up
N/A Completed N=118 Randomized Single-blind Treatment

Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma

Source: ClinicalTrials.gov NCT02566902 ↗
Enrolled (actual)
118
Serious AEs
0.0%
Results posted
May 2021
Primary outcomePrimary: Change in FEV1 (% Predicted) — 13.8; 9.1 %predicted — p=0.04

Summary

This is a blinded observer randomized controlled trial comparing two nebulizer devices. The objective of this study is to evaluate the efficacy of two different nebulizers.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in FEV1 (% Predicted)
13.8; 9.1 0.04 sig
SECONDARY
Change in PAS Score (Points on a Scale)
-1; -2 0.29
SECONDARY
Change in PASS Score (Points on a Scale)
-1; -1 0.97
SECONDARY
Percentage of Patients Requiring Inpatient Hospital Admission (% of Subjects)
11; 11 0.96
SECONDARY
Emergency Department Length of Stay (Minutes)
246.3; 246.2 0.99
SECONDARY
Percentage of Patients Experiencing Medication Side Effects (%)
5; 5 1.00
SECONDARY
Total Quantity of Albuterol Given in the Emergency Department (mg)
18.2; 18.7
SECONDARY
Change Respiratory Rate (Breaths Per Minute)
-3.1; -3.2
SECONDARY
Change in Heart Rate (Beats Per Minute)
4.34; 15.05

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 6 years and < 18 years
  • History of physician diagnosed asthma
  • Presenting to ED with breathing difficulty or cough
  • Initial FEV1 25%-70% predicted
  • Parent or guardian speaks English or Spanish.

Exclusion Criteria

  • Pediatric Asthma Score of 0
  • Pregnancy or breast-feeding
  • Immediate resuscitation required
  • Chronic lung disease (other than asthma)
  • Congenital heart disease
  • Neuromuscular disease
  • Suspected intrathoracic foreign body
  • Allergy or other contraindication to study medication
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02566902). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search